SCOTUS Grants Certiorari on Appointments Clause Issue

article II constitution fed circuit watch patent PTAB scotus watch

In its orders of October 13, 2020, the U.S. Supreme Court granted petitions for writ of certiorari to three cases involving Arthrex, Inc., dealing with the constitutionality of the PTAB’s judges: United States v. Arthrex, Inc. (Docket No. 19-1434), Smith & Nephew, Inc. v. Arthrex, Inc. (Docket No. 19-1452), and Arthrex, Inc. v. Smith & …

Continue Reading

SCOTUS Watch: SCOTUS Finds Adding “.com” to “Booking” Makes it a Non-Generic Registrable Mark

distinctiveness genericism scotus watch trademark

In a major ruling, the U.S. Supreme Court held in U.S.P.T.O. v. B.V.,[1] that an otherwise generic mark used in commerce conveys source-identifying characteristics when used with the “.com” top-level domain (TLD).  In her majority opinion, Justice Ginsburg opined that since only one domain name owner can hold one particular domain name at any …

Continue Reading

SCOTUS Watch: SCOTUS Decides Against Wading into 101 Quagmire

101 11th amendment patent patent eligible subject matter scotus watch sovereign immunity

On January 13, 2020, the U.S. Supreme Court denied petitions for writs of certiorari in four cases dealing with patent subject matter-eligibility: HP Inc. v. Berkheimer, Hikma Pharms., Inc. v. Vanda Pharms., Inc., Garmin USA, Inc. v. Cellspin Soft, Inc., and Athena Diagnostics, Inc. v. Mayo Collaborative Servs., which was discussed earlier on this blog.  …

Continue Reading

SCOTUS Watch: Patent Eligibility Showdown Looming Before Supreme Court

101 patent patent eligible subject matter scotus watch

On January 10, 2020, the U.S. Supreme Court will discuss at its first conference meeting whether or not to take up one to four cases dealing with patent eligibility under 35 U.S.C. §101.  Patent eligibility has been a contentious source of patent application rejections or invalidations during post-grant litigation.  Medical diagnostics and software have been …

Continue Reading

SCOTUS Watch: High Court Strikes Down USPTO Attorney’s Fees

fees patent scotus watch trademark

On December 11, 2019, the U.S. Supreme Court affirmed the Court of Appeals for the Federal Circuit’s en banc ruling in Peter v. NantKwest, Inc.,[1] holding that the USPTO was not entitled to attorney’s fees under the 35 U.S.C. §145.  Our discussion of the Fed Circuit’s en banc opinion, affirmed by the Supreme Court, was …

Continue Reading

SCOTUS Watch: Bar on Immoral and Scandalous Marks Violates First Amendment

1st amendment scotus watch section 2(a) trademark

On June 24, 2019, the U.S. Supreme Court handed down Iancu v. Brunetti,[1] dealing with the Lanham Act’s Section 2(a) bars to trademark registration’s collision against the First Amendment brick wall; the Justices in a 6-3 vote struck down the immoral and scandalous clause of §2(a) in a somewhat mixed-up and divided Court.  Brunetti is …

Continue Reading

SCOTUS Watch: Government Is Not a Person for Purposes of AIA

AIA CBM IPR patent PGR scotus watch

On June 10, 2019, the U.S. Supreme Court overturned the Court of Appeals for the Federal Circuit in Return Mail, Inc. v. United States Postal Service,[1] in which the Court held that the Government was not a “person” for definitions of the America Invents Act (AIA). The case originates from Return Mail’s patent, U.S. Patent …

Continue Reading

SCOTUS Watch: Costs Recovered Limited as Specified in Copyright Act

copyright fees scotus watch trials

In the second copyright case decided by the U.S. Supreme Court on March 4, 2019, Rimini Street, Inc. v. Oracle USA, Inc.,[1] the high court dealt with the question of whether “full costs” is more than the costs set forth in either 28 U.S.C. §1821 or §1920. Both Oracle and Rimini Street are competitors in …

Continue Reading

SCOTUS Watch: On-Sale Bar Still Valid Under AIA

102 AIA on-sale bar patent pre-AIA scotus watch

On January 22, 2019, the United States Supreme Court handed down a highly anticipated ruling that has caused measurable discrepancies amongst the patent community after the America Invents Act (AIA) was enacted.  That ruling, Helsinn Healthcare S.A. v. Teva Pharms. USA, Inc.,[1] held that the on-sale bar applies to confidential sales more than one year …

Continue Reading

SCOTUS Watch: Supreme Court Grants Certiorari in Copyright Cost Row

copyright fees scotus watch

On September 27, 2018, the U.S. Supreme Court granted certiorari in Rimini Street, Inc. v. Oracle USA, Inc.,[1] in order to resolve a split in the circuits related to prevailing copyright litigant’s awarding of “full costs,” and whether that means only taxable costs under 28 U.S.C. §1920 – court and witness fees, copying costs, expert …

Continue Reading